{{Rsnum
|rsid=7019241
|Gene=GOLM1
|Chromosome=9
|position=86078545
|Orientation=plus
|GMAF=0.2635
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GOLM1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 86.7 | 12.4 | 0.9
| HCB | 19.0 | 52.6 | 28.5
| JPT | 20.4 | 47.8 | 31.9
| YRI | 36.1 | 52.4 | 11.6
| ASW | 45.6 | 42.1 | 12.3
| CHB | 19.0 | 52.6 | 28.5
| CHD | 22.9 | 45.0 | 32.1
| GIH | 55.0 | 37.0 | 8.0
| LWK | 59.1 | 33.6 | 7.3
| MEX | 72.4 | 25.9 | 1.7
| MKK | 66.7 | 28.8 | 4.5
| TSI | 79.4 | 18.6 | 2.0
| HapMapRevision=28
}}
[[rs7019241]], a SNP in the [[GOLM1]] gene, is associated with reduced risk for [[Alzheimer's disease]] in a study of ~1100 Canadian patients. The protective allele appears to be [[rs10868366(T)]], giving an odds ratio of 0.54 (CI: 0.38 - 0.75). {{PMID|17998437}}

{{PMID Auto
|PMID=19204163
|Title=GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results.
|OA=1
}}

{{PMID Auto
|PMID=20574532
|Title=Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=22167654
|Title=Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}